- Is the patient allowed palliative radiotherapy whilst on treatment?
Please refer to the treatment arm-specific ‘Supportive treatment’ section of the Protocol. Guidance will only be included here if we have received it for that particular drug. If it is not included, please email Glo-BNHL@trials.bham.ac.uk for further guidance.
- Do you allow eligibility waivers?
It is the CRCTU’s policy not to allow eligibility waivers. There will be no exceptions. The patient should meet both the Core and Arm-specific eligibility criteria in the latest version of the Protocol with R&D Approval in place at your site.
- Is there a maximum treatment interruption length allowed?
Please refer to the Arm-specific ‘Dose Modifications’ section of the Protocol.